Shuttle Pharmaceuticals Holdings, Inc.
SHPH · XNASCIK 1757499fmd_0GSFA0AV1GR5JGX0VNTYQYJZHCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Jun 30, 2026, 22 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net interest income | – | – | 0 | 0 | – |
| Research and development | 1 | 1 | 4 | 4 | 4 |
| Total operating expenses | 2 | 2 | 6 | 8 | 12 |
| Operating income | (2) | (2) | (6) | (8) | (12) |
| Interest expense | 0 | 1 | 2 | – | – |
| Interest and investment income | – | – | 0 | 0 | 0 |
| Other non-operating income (expense) | 1 | (3) | (1) | (1) | 0 |
| Income before taxes | (1) | (5) | (7) | – | 12 |
| Net income | (1) | (5) | (7) | (9) | (12) |
| Net income to common shareholders | (1) | (7) | (7) | – | – |